[1]
A. N. Meidina, N. Ramadhanti, D. F. Istiqomah, Y. D. Putri, and N. A.- zahra Hasibuan, “Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review”, JOHMPE, vol. 3, no. 1, Feb. 2025.